Copyright
©2010 Baishideng.
World J Gastroenterol. Feb 7, 2010; 16(5): 583-587
Published online Feb 7, 2010. doi: 10.3748/wjg.v16.i5.583
Published online Feb 7, 2010. doi: 10.3748/wjg.v16.i5.583
Table 1 Characteristics of the patients
| UC | CD | ASLC | |
| n | 17 | 11 | 8 |
| Male (%) | 47.1 | 54.5 | 50.0 |
| Mean age (± SE, yr) | 42.0 ± 3.3 | 44.0 ± 3.9 | 45.6 ± 10.5 |
| Mean disease duration (± SE, mo) | 75 ± 23 | 50 ± 27 | NA |
| Montreal classification (%) | |||
| E1 | 0 | NA | NA |
| E2 | 70.6 | NA | NA |
| E3 | 29.4 | NA | NA |
| L1 | NA | 0 | NA |
| L2 | NA | 63.6 | NA |
| L3 | NA | 36.4 | NA |
| Analyzed segment (%) | |||
| Rectum | 64.7 | 36.4 | 71.4 |
| Left colon | 35.3 | 45.4 | 14.3 |
| Right colon | 0.0 | 18.2 | 14.3 |
| Treatment (%) | |||
| 5-aminosalicylic acid | 35.3 | 18.2 | 0.0 |
| Corticosteroids | 35.3 | 27.3 | 0.0 |
| Azathioprine | 17.6 | 18.2 | 0.0 |
| Infliximab | 0.0 | 18.2 | 0.0 |
- Citation: Sokol H, Vasquez N, Hoyeau-Idrissi N, Seksik P, Beaugerie L, Lavergne-Slove A, Pochart P, Marteau P. Crypt abscess-associated microbiota in inflammatory bowel disease and acute self-limited colitis. World J Gastroenterol 2010; 16(5): 583-587
- URL: https://www.wjgnet.com/1007-9327/full/v16/i5/583.htm
- DOI: https://dx.doi.org/10.3748/wjg.v16.i5.583